BIOVEST INTERNATIONAL, INC.
763-786-0302
8500 Evergreen Blvd.
Minneapolis, Minnesota
55433
, USA
Fax: 763-786-0915
Website Links: Biovest International, Inc. | About Biovest | AutovaxID | BiovaxID Publications | BVTI Stock Quote | Cancer Vaccine Technology | Cell Culture Instruments... | Collaborations & Partnering | Contract Manufacturing | Management Team & Directors | Media Center | Personalized Cancer Vaccine | Phase III Clinical Trial... | Phase III Isotope Analysis | SEC Filings | Section 16 Filings
Products & Services
| Year Established | 1981 |
Web Site Results
- Welcome to Biovest
- Main Menu HomeAbout BiovestCorporate ProfileManagement Team & DirectorsCollaborations & PartneringCareersCancer Vaccine TechnologyBiovaxID Personalized Cancer VaccineBiovaxID PublicationsPhase III Isotope AnalysisPhase III Clinical Trial SummaryAutovaxID Cell Culture Instruments & ServicesBioreactor SystemsContract ManufacturingCustomer ServiceInvestor RelationsIR Center & FAQBVTI Stock
- BiovaxID Phase III Clinical Trial Summary
- BiovaxID Phase III Clinical Trial Summary Written by Administrator Thursday, 13 January 2011 18:39 At the 2009 American Society of Clinical Oncology (ASCO) Annual Meeting Plenary Session, Biovest presented the results
- Phase III Clinical Trial...
Main Menu HomeAbout BiovestCorporate ProfileManagement Team & DirectorsCollaborations & PartneringCareersCancer Vaccine TechnologyBiovaxID Personalized Cancer VaccineBiovaxID PublicationsPhase III Isotope AnalysisPhase III Clinical Trial SummaryAutovaxID Cell Culture Instruments & ServicesBioreactor SystemsContract ManufacturingCustomer ServiceInvestor RelationsIR Center & FAQBVTI Stock
- AutovaxID
AutovaxID Written by Administrator Monday, 21 June 2010 20:40 Biovest has developed the AutovaxID bioreactor as an ideal production platform (cGMP compliant) for the scalable manufacture of difficult-to-produce biologics
- AutovaxID
- Main Menu HomeAbout BiovestCorporate ProfileManagement Team & DirectorsCollaborations & PartneringCareersCancer Vaccine TechnologyBiovaxID Personalized Cancer VaccineBiovaxID PublicationsPhase III Isotope AnalysisPhase III Clinical Trial SummaryAutovaxID Cell Culture Instruments & ServicesBioreactor SystemsContract ManufacturingCustomer ServiceInvestor RelationsIR Center & FAQBVTI Stock